Trump Denies Intention to Fire FDA Chief

Summary

President Trump has denied reports that he intends to fire FDA Commissioner Marty Makary Zhitong. This follows rumors of his dismissal [citation:23, 28] after Trump reportedly criticized Makary for the slow pace of approvals for flavored e-cigarettes and nicotine products [citation:22, 24, 29].

Impact Analysis

So they’re basically playing the classic ‘short leash’ game here. Trump’s denial of firing FDA Commissioner Marty Makary [Zhitong] follows reports that he was actually tearing into him over the weekend for being too slow on flavored e-cigarette and nicotine approvals [[citation:22, 24]]. This isn’t a vote of confidence; it’s a public performance to force a policy pivot.

Remember, we’ve seen this playbook before with Fed Chair Powell—public threats followed by a temporary reprieve [[citation:4, 14]]. The real signal is that the White House is now directly micromanaging the FDA’s tobacco office. If you’re looking at the nicotine and vaping sector, this is a clear green light. The administration is frustrated with regulatory ‘red tape’ and wants these products moving through the pipeline immediately.

Bottom line: Makary stays for now, but the FDA’s independence on nicotine regulation just took a massive hit. Expect a flurry of approvals soon to appease the West Wing. The market might see ‘stability’ in the denial, but the real story is the forced acceleration of the vaping industry.